| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 191.38B | 190.55B | 192.49B | 193.83B | 178.62B | 163.54B |
| Gross Profit | 40.66B | 41.69B | 40.89B | 41.34B | 34.25B | 36.63B |
| EBITDA | 27.10B | 22.19B | 28.92B | 27.52B | 21.12B | 21.79B |
| Net Income | 8.60B | 9.39B | 8.87B | 8.20B | 3.84B | 8.09B |
Balance Sheet | ||||||
| Total Assets | 282.31B | 305.58B | 291.78B | 290.11B | 264.70B | 255.40B |
| Cash, Cash Equivalents and Short-Term Investments | 58.64B | 61.62B | 62.46B | 52.01B | 45.35B | 40.79B |
| Total Debt | 26.92B | 30.19B | 33.57B | 35.65B | 40.14B | 38.94B |
| Total Liabilities | 90.45B | 92.56B | 93.14B | 100.47B | 98.80B | 95.64B |
| Stockholders Equity | 158.59B | 174.97B | 162.95B | 157.50B | 133.90B | 128.94B |
Cash Flow | ||||||
| Free Cash Flow | 3.40B | 10.60B | 13.00B | 14.23B | 11.63B | 8.58B |
| Operating Cash Flow | 5.44B | 22.72B | 21.74B | 24.39B | 21.09B | 19.86B |
| Investing Cash Flow | -2.81B | -13.54B | -4.58B | -9.61B | -14.57B | -13.44B |
| Financing Cash Flow | -1.54B | -11.58B | -9.93B | -10.55B | -3.92B | -10.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥692.20B | 45.41 | ― | 2.60% | 1.89% | -39.75% | |
74 Outperform | ¥83.76B | 8.59 | ― | 3.85% | -1.01% | 8.57% | |
74 Outperform | ¥553.56B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
69 Neutral | ¥110.72B | 12.01 | ― | 5.78% | 1.24% | 186.45% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥403.46B | -20.09 | 3.70% | 3.42% | 4.24% | 39.02% | |
55 Neutral | ¥2.92B | 24.21 | ― | 3.03% | 2.78% | ― |